Front Cover

News

In Brief

Research Feature

Research News and Notes

Out and About

Notable

Papers & Presentations

Memorial's Archival Treasures

Classified

Flashback

Obituaries

Search This Issue

Division of University Relations Homepage

E-mail us

 


Research contracts

(June 22, 2000, Gazette)

The following is a list of some members of the university community who have received research contracts. The Office of Research has supplied information about the contract recipient, funding source, contract value, and the research topic. This list is not meant to reflect all of the research going on at Memorial now, but rather who received funding for the months of September, October, November And December, 1999.

Brown, Joseph, Ocean Sciences Centre; Effect of fish behaviour on acoustic and trawl sampling in research vessel surveys; Fisheries and Oceans Canada; $7,000.

Burton, Margaret, Biology; Effects of Dietary Protein, Energy & Glutamic Acid Intake On Gonadal Development in Salmonids — Phase 2a & 2b; Canadian Centre for Fisheries Innovation & Others; $33,408.

Burton, Margaret, Biology; Effects of Dietary Protein, Energy and Glutamic Acid Intake on Gonadal Development in Salmonids — Year 2; Canadian Centre for Fisheries Innovation and Others; $96,032.

Colbo, Murray, Biology; Extraction of EOCL from cod; Fisheries and Oceans Canada; $3,000.

Colbo, Murray, Biology; Extraction of the pesticide Azamethiphos from lobster; Fisheries and Oceans Canada; $3,000.

Driedzic, William, Ocean Sciences Centre; Business Manager for Aquaculture Research and Development Facility at the OSC; ACOA; $67,500.

Haedrich, Richard, Biology; Deepwater Program: Northern Gulf of Mexico Continental Shelf Slope Habitats and Benthic Ecology; Texas Engineering Experiment Station; $25,723.

Hooper, Robert and McKeever, Tom, Biology/Marine Institute; The effects of environmental factors on the growth and quality of green sea urchin gonads; Canadian Centre for Fisheries Innovation and Others; $90,895.85.

Joyce, Carol, Medicine; Prevention Study: A Study on the Prevention of NIDDM in Subjects with IGT; Bayer Inc.; increase $2,600; revised value $233,840.

Kaiser, Stephanie and Hollett, Peter, Medicine; Clinical trial research: HIC No. 99.71; Canadian Business; $8,374.

Keough, Kevin, Biochemistry; Continuation Project 1999: Liposome Systems for use in Aquaculture; Canadian Centre for Fisheries Innovation and Others; $241,725.

Khraishi, Majed, Medicine; A multi-center phase II continuation study of the human anti-TNF antibody D2E7 administered as subcutaneous injections in patients with rheumatoid arthritis treated with methotrexate; Knoll Pharma Inc.; $45,812.

Khraishi, Majed, Medicine; Clinical trial research: HIC No. 99.124; Canadian Business; $138,900.

Khraishi, Majed, Medicine; Ibandronate in osteoporosis and osteopenia; Hoffmann-La Roche; $93,600.

Khraishi, Majed, Medicine; A multi-center randomized placebo-controlled phase II study of the human anti-TNF antibody D2E7 administered as subcutaneous injections in rheumatoid arthritis patients treated with methotrexate; Knoll Pharma Inc.; $102,700.

King, Wayne, P.J. Gardiner Institute; Program Administrative Services for ACOA; ACOA (PWGSC); $200,000.

Montevecchi, William, Psychology; Birds 2000 — Living on the Edge Conference; ACOA; $157,178.

Parfrey, Patrick, Medicine; A double-blind, randomized, placebo-controlled, multicenter study to assess the safety and efficacy of an oral calcimimetic agent (AMG 073) in secondary hyperparathyroidism of end-stage renal disease (ESRD); Canadian Business; $141,100.

Patel, Thakor, Biology; Investigate the thermal resistance of listeria monocytogenes; Canadian Centre for Fisheries Innovation and Others; $11,490.

Pryse-Phillips, William; Goodridge, Alan; Ogunyemi, Abayomi; Stefannelli, Mark and Wong, Anna, Medicine; BRAVO study; SmithKline Beecham Pharma; $117,000.

Rawson, Nigel, Medicine; A Comparison of Regulatory Approval Times for New Chemical Entities in Canada, Australia, Sweden, the United Kingdom and the United States, 1996-1998; Canada's Research-Based Pharmaceutical Companies (Rx&D); $17,550.

Rose, Barry, Medicine; Clinical trial research: HIC No. 99.80; Canadian Business; $70,000.

Sussex, Bruce, Medicine; Omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE); Bristol-Myers Squibb Pharmaceutical Research Institute; $61,320.

Sussex, Bruce, Medicine; Clinical trial research: HIC No. 99.63; Canadian Business; $218,500.